PL340456A1 - Novel oral dosage form of carvedilol - Google Patents

Novel oral dosage form of carvedilol

Info

Publication number
PL340456A1
PL340456A1 PL98340456A PL34045698A PL340456A1 PL 340456 A1 PL340456 A1 PL 340456A1 PL 98340456 A PL98340456 A PL 98340456A PL 34045698 A PL34045698 A PL 34045698A PL 340456 A1 PL340456 A1 PL 340456A1
Authority
PL
Poland
Prior art keywords
carvedilol
dosage form
oral dosage
novel oral
novel
Prior art date
Application number
PL98340456A
Inventor
Choon K Oh
Original Assignee
Boehringer Mannheim Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp
Publication of PL340456A1 publication Critical patent/PL340456A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
PL98340456A 1997-11-12 1998-11-12 Novel oral dosage form of carvedilol PL340456A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6545697P 1997-11-12 1997-11-12
PCT/US1998/024102 WO1999024017A1 (en) 1997-11-12 1998-11-12 Novel oral dosage form for carvedilol

Publications (1)

Publication Number Publication Date
PL340456A1 true PL340456A1 (en) 2001-02-12

Family

ID=22062830

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98340456A PL340456A1 (en) 1997-11-12 1998-11-12 Novel oral dosage form of carvedilol

Country Status (14)

Country Link
EP (1) EP1030651A4 (en)
JP (1) JP2001522794A (en)
KR (1) KR20010031952A (en)
CN (1) CN1285738A (en)
AU (1) AU751117B2 (en)
BR (1) BR9814127A (en)
CA (1) CA2309542A1 (en)
HU (1) HUP0004345A3 (en)
IL (1) IL136028A0 (en)
NO (1) NO20002439D0 (en)
NZ (1) NZ504418A (en)
PL (1) PL340456A1 (en)
TR (1) TR200001362T2 (en)
WO (1) WO1999024017A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275953A1 (en) 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
AU2003288608A1 (en) * 2002-12-20 2004-07-14 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
EP1691789B1 (en) 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
CN101453996B (en) * 2006-04-03 2016-05-11 伊萨·奥迪迪 Drug delivery composition
TWI415604B (en) 2009-09-29 2013-11-21 Tsh Biopharm Corp Ltd Controlled release carvediolol formulation
ES2600894T3 (en) * 2010-02-22 2017-02-13 Daiichi Sankyo Company, Limited Solid sustained release preparation for oral use
WO2011102504A1 (en) * 2010-02-22 2011-08-25 第一三共株式会社 Sustained-release solid preparation for oral use
JP5870023B2 (en) * 2010-02-22 2016-02-24 第一三共株式会社 Oral sustained-release solid preparation
WO2014034929A1 (en) 2012-09-03 2014-03-06 第一三共株式会社 Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
KR102158339B1 (en) * 2016-02-05 2020-09-21 삼진제약주식회사 Carvedilol immediate release formulation having improved madescent
KR102525298B1 (en) 2020-12-30 2023-04-25 단국대학교 천안캠퍼스 산학협력단 Carvedilol loaded solid dispersion with increased oral bioavailability and methods for their preparation
KR102492147B1 (en) 2020-12-30 2023-01-26 단국대학교 천안캠퍼스 산학협력단 Carvedilol loaded solid oral compositions using self-nanoemulsifying drug delivery system and methods for their preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (en) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
JPS5598120A (en) * 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
DK0554306T3 (en) * 1990-10-23 1996-03-18 Davband Pty Ltd Backrest for a chair or seat
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
DE19637082A1 (en) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Rapidly disintegrating pellets

Also Published As

Publication number Publication date
CA2309542A1 (en) 1999-05-20
NO20002439L (en) 2000-05-11
IL136028A0 (en) 2001-05-20
BR9814127A (en) 2000-10-03
EP1030651A1 (en) 2000-08-30
HUP0004345A3 (en) 2001-10-29
EP1030651A4 (en) 2006-05-31
TR200001362T2 (en) 2000-09-21
KR20010031952A (en) 2001-04-16
NO20002439D0 (en) 2000-05-11
AU1456999A (en) 1999-05-31
WO1999024017A1 (en) 1999-05-20
HUP0004345A2 (en) 2001-06-28
CN1285738A (en) 2001-02-28
NZ504418A (en) 2003-02-28
AU751117B2 (en) 2002-08-08
JP2001522794A (en) 2001-11-20

Similar Documents

Publication Publication Date Title
IL195339A0 (en) Solid oral dosage forms of valsartan
PL341428A1 (en) Oral pharmacological dosage form of prolonged release type
HUP9603064A2 (en) New oral pharmaceutical dosage form
HUP9903407A3 (en) Oral pharmaceutical preparation containing ibandronat
EP1020193A4 (en) Oral preparation
AU7375598A (en) Stable oral pharmaceutical dosage forms
HUP0203204A3 (en) Oral dosage forms
HUP9901454A3 (en) Dosage form of ibuprofen
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
HUP0100090A3 (en) Oral care composition
HUP0003757A3 (en) Oral pharmaceutical compositions of levosimendan
PL335502A1 (en) Paracetamol containing oral tablet
IL138192A0 (en) Controlled release oral dosage forms
PL340456A1 (en) Novel oral dosage form of carvedilol
HU9500618D0 (en) Oral pharmaceutical compositions
HUP0201667A3 (en) Oral form of administration
GB9718616D0 (en) Oral vaccine
ZA974125B (en) Oral pharmaceutical compositions
GB9930266D0 (en) Oral administration of beneficial substances
HK1047232A1 (en) Oral dosage forms
SI1043976T1 (en) Oral pharmaceutical extended release dosage form
GB9718683D0 (en) Novel dosage form
HUP0101012A3 (en) Pharmaceutical composition for oral administration
GB9711046D0 (en) Oral pharmaceutical compositions
GB9707576D0 (en) Enhancement of oral hygiene